Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 376

Results For "NDA"

4491 News Found

First oral diabetes treatment approved in Europe for use during pregnancy
Drug Approval | February 28, 2022

First oral diabetes treatment approved in Europe for use during pregnancy

In a European work-sharing procedure (WSP), Glucophage was approved as the first oral anti-diabetic medication to be used safely from conception to birth


Researchers develop a fast, efficient tech to remove pollutants from water
Sustainability | February 28, 2022

Researchers develop a fast, efficient tech to remove pollutants from water

The method shows the removal of seven types of PFAS – even when all of them are found in the same unit of fluid – at a level of efficiency that approaches 90%, and it does so within a few minutes


Cabinet approves Ayushman Bharat Digital Mission at an outlay of Rs 1,600 cr.
Policy | February 27, 2022

Cabinet approves Ayushman Bharat Digital Mission at an outlay of Rs 1,600 cr.

Citizens will be able to create their ABHA (Ayushman Bharat Health Account) numbers, to which their digital health records can be linked


New data reinforces efficacy of Tezspire
Biotech | February 27, 2022

New data reinforces efficacy of Tezspire

These results are being presented at the 2022 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting


DiscGenics presents positive Phase1/2 study of Cell therapy for degenerative disc disease
Biotech | February 27, 2022

DiscGenics presents positive Phase1/2 study of Cell therapy for degenerative disc disease

Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and quality of life by 12 weeks following intradiscal injection


Oxford BioDynamics launches its Checkpoint Inhibitor response test in the US
Biotech | February 27, 2022

Oxford BioDynamics launches its Checkpoint Inhibitor response test in the US

First-of-its-kind precision medicine test to predict a cancer patient’s response to an Immune Checkpoint Inhibitor (ICI)


VBI’s 3-antigen Hepatitis B vaccine gets CHMP nod
Biotech | February 27, 2022

VBI’s 3-antigen Hepatitis B vaccine gets CHMP nod

If approved, PreHevbri will be the only approved 3-antigen hepatitis B vaccine for adults in the E.U.


8 bulk drugs projects commissioned under PLI scheme
News | February 26, 2022

8 bulk drugs projects commissioned under PLI scheme

The bulk drug plants that have already been commissioned include CDA, para amino phenol, atorvastatin, sulfadiazine, oxcarbazepine, levofloxacin, carbidopa and levodopa


IMI releases tamper evident caps with DoseID certified RFID
Digitisation | February 26, 2022

IMI releases tamper evident caps with DoseID certified RFID

Tamper evident caps with incorporated RFID technology offer a significant reduction in RFID implementation costs


Wockhardt Hospitals, Mira Road opens centre for sports medicine
Hospitals | February 25, 2022

Wockhardt Hospitals, Mira Road opens centre for sports medicine

The facility is spread across 215000 sq. feet and provides super-speciality care